HOT OFF THE PRESS: Blood pressure and outcome in primary and secondary prevention is all about risk

2021 ◽  
Vol 69 ◽  
Keyword(s):  
Blood Pressure ◽  
Secondary Prevention ◽  
Primary And Secondary Prevention ◽  
The Press

scholarly journals Modern opportunities for lifestyle changes and statin therapy in the prevention of cardiovascular diseases

2017 ◽  
Vol 8 (3) ◽  
pp. 39-4
Author(s):  
M. G Bubnova
Keyword(s):  
Physical Activity ◽  
Blood Pressure ◽  
Body Weight ◽  
Cardiovascular Risk ◽  
Cardiovascular Diseases ◽  
Secondary Prevention ◽  
Lifestyle Changes ◽  
Primary And Secondary Prevention ◽  
Positive Effects ◽  
Quitting Smoking

The presented review concerns the problem of lifestyle changes in primary and secondary prevention of cardiovascular diseases. The results of studies highlighting the positive effects of quitting smoking, controlling blood pressure, body weight and cholesterol on the risks of developing cardiovascular diseases and their complications are highlighted. Attention is paid to the principles of the formation of a healthy diet and increased physical activity. The principles of prescribing statins with different categories of cardiovascular risk of the patient with emphasis on the new statin - pitavastatin are indicated.

scholarly journals Analysis of the frequency of vascular comorbidity in patients with recurrent acute stroke

2015 ◽  
pp. 45-49
Author(s):  
O. N. Mikitey ◽  
N. K. Svyrydova ◽  
N. P. Pavliuk
Keyword(s):  
Risk Factors ◽  
Atrial Fibrillation ◽  
Blood Pressure ◽  
Secondary Prevention ◽  
Oval Window ◽  
High Cholesterol ◽  
Primary And Secondary Prevention ◽  
High Incidence ◽  
The Brain ◽  
Vascular Comorbidity

Stroke is an important medical and social problem, which occupies the second place in the population figures for mortality and one of the first rate for disability. Given the magnitude of the incidence, severity, effects, high incidence of recurrence great importance becomes its primary and secondary prevention that provides impact on the risk factors: high blood pressure, diabetes, high cholesterol, atrial fibrillation, sickle-cell anemia, open oval window, alcoholism. Prognosis depends on many factors, primarily on the amount and location of lesions of the brain, the severity of comorbidity and the patient’s age.

Management of cardiovascular risk in systemic lupus erythematosus: a systematic review

Lupus ◽  
2017 ◽  
Vol 26 (13) ◽  
pp. 1407-1419 ◽  
Author(s):  
C Andrades ◽  
C Fuego ◽  
S Manrique-Arija ◽  
A Fernández-Nebro
Keyword(s):  
Systematic Review ◽  
Systemic Lupus Erythematosus ◽  
Blood Pressure ◽  
Secondary Prevention ◽  
Lupus Erythematosus ◽  
Cardiovascular Events ◽  
Lipid Lowering ◽  
Primary And Secondary Prevention ◽  
Systemic Lupus ◽  
Lipid Lowering Drugs

Systemic lupus erythematosus is associated with accelerated atherosclerosis and increased risk of cardiovascular complications. The aim of this study was to review the effectiveness of interventions for primary and secondary prevention of cardiovascular events and mortality and to review the effectiveness of interventions for cardiovascular risk factor reduction in systemic lupus erythematosus patients. A systematic review was conducted. Electronic databases Medline and Embase (1961–2015) were searched. Nineteen articles met the inclusion criteria and were selected. Low-calorie and/or low glycaemic index calories may be a useful option for secondary prevention in obese patients with systemic lupus erythematosus, and exercise would be useful in improving the endothelial function measured by flow-mediated dilation in this group of patients. The use of lipid-lowering drugs may improve the lipid profile in patients with systemic lupus erythematosus and hyperlipidaemia, but the effect of this treatment on overall cardiovascular mortality remains unknown. Antiplatelets, anticoagulants, antimalarials and lipid-lowering drugs may be effective in the primary and secondary prevention of major cardiovascular events, such as acute myocardial infarction or stroke. Similarly, lipid-lowering drugs and antimalarial drugs appear to reduce the serum levels of total cholesterol, low-density lipoprotein, glucose, diastolic blood pressure and calcium deposition at the coronary arteries. They may also improve insulin resistance and the level of high-density lipoproteins. It appears that treatment with antihypertensive drugs reduces blood pressure in patients with systemic lupus erythematosus, but the available studies are of low quality.

Sign in / Sign up

Export Citation Format

Share Document